<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Hanna Schou | Activity</title>
	<link>https://www.catswannabecats.com/members/soyvault1/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/soyvault1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Hanna Schou.</description>
	<lastBuildDate>Tue, 30 Jun 2026 07:59:13 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e48e942bfb7af738c85a18105d1304e0</guid>
				<title>Hanna Schou posted an update: Mitochondrial and cognitive dysfunctions have long been [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23586/</link>
				<pubDate>Sun, 08 Jun 2025 09:43:59 -0400</pubDate>

									<content:encoded><![CDATA[<p>Mitochondrial and cognitive dysfunctions have long been associated with major depressive disorders (MDDs). Studies have shown that Memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, possesses an antidepressant-like effect. Hence, the NMDA receptor can be a better therapeutic target for MDD. Therefore, the present study was designed to&hellip;<span class="activity-read-more" id="activity-read-more-23586"><a href="https://www.catswannabecats.com/activity/p/23586/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ca565df23ffb4368fd1560cc6db8c75e</guid>
				<title>Hanna Schou posted an update: Owing to concerns regarding adequate oncological outcomes [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/18710/</link>
				<pubDate>Wed, 04 Jun 2025 10:23:01 -0400</pubDate>

									<content:encoded><![CDATA[<p>Owing to concerns regarding adequate oncological outcomes and perioperative complications, minimally invasive distal pancreatectomy (MIDP) for pancreatic ductal adenocarcinoma (PDAC) has limited generalizability. The aim of this study was to assess the perioperative and oncologic outcomes of MIDP compared with open distal pancreatectomy (ODP) for&hellip;<span class="activity-read-more" id="activity-read-more-18710"><a href="https://www.catswannabecats.com/activity/p/18710/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">1e6eca81cb04d00b36cde169e8cb5330</guid>
				<title>Hanna Schou posted an update: To determine the effectiveness of erenumab in treating [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4334/</link>
				<pubDate>Sat, 31 May 2025 12:36:59 -0400</pubDate>

									<content:encoded><![CDATA[<p>To determine the effectiveness of erenumab in treating headaches in idiopathic intracranial hypertension (IIH) in whom papilledema had resolved.</p>
<p> Disability in IIH is predominantly driven by debilitating headaches with no evidence for the use of preventative therapies. Headache therapy in IIH is an urgent unmet need.</p>
<p> A prospective,&hellip;<span class="activity-read-more" id="activity-read-more-4334"><a href="https://www.catswannabecats.com/activity/p/4334/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">3e77b69ce478e7f40579e4742ad7d48c</guid>
				<title>Hanna Schou became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4188/</link>
				<pubDate>Sat, 31 May 2025 12:18:20 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>